Live Breaking News & Updates on Renal Medicine

Stay updated with breaking news from Renal medicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

How Can Cardiovascular Risk Be Reduced in Kidney Dialysis?

The experimental IL-6 inhibitor clazakizumab improves key inflammation markers in one study, whereas another shows lower risks with home hemodialysis vs peritoneal dialysis. ....

United States , Stanford University , University Of Cincinnati , Peter Stenvinkel , Glenn Chertow , Silvi Shah , Division Of Nephrology , Division Of Renal Medicine At Karolinska Institutet , Stanford University School Of Medicine , European Renal Association Congress , European Renal Association , Stanford University School , Albumin Improvements Called , Renal Medicine , Karolinska Institutet , Medscape Medical , United States Renal Data System ,

Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024

Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , San Carlos , University Of Illinois , Sangeeta Bhorade , Ali Zarrinpar , Elliot Aguilar , Hossein Tabriziani , Zahraa Hajjiri , Milagros Samaniego Picota , Suphamai Bunnapradist , Clinical Laboratory Improvement Amendments , University Of Florida Health , Umass Memorial Health Care , Umass Chan School Of Medicine , American Transplant Congress , University Of Florida College Medicine , Natera Inc , Prospera Kidney , Donor Cell Free , Kidney Transplants , Differential Rejection Analysis , Antibody Mediated , T Cell Mediated Rejections , Significant Variation , Kidney Transplant Recipients , Future Kidney Allograft ,

Invizius's Pioneering Dialysis Product H-Guard® Completes First In-Human Clinical Study

/PRNewswire/ Invizius Limited ("Invizius"), a biotechnology company developing breakthrough treatments for patients on dialysis, announces that eight. ....

United Kingdom , Glasgow City , Duha Ilyas , Sandip Mitra , Leonard Ebah , Magnus Nicolson , Ilyas Duha , Professor Of Renal Medicine At Manchester University , Care Research , Manchester University , Prnewswire Invizius Limited , Manchester Clinical Research Facility , National Institute For Health , Acute Kidney Injury , National Institute , Priming Solution , Manchester Royal Infirmary , Professor Sandip Mitra , Continuous Renal Replacement Therapy , Intensive Care Unit , Professor Mitra , Consultant Nephrologist , Renal Medicine ,

Invizius's Pioneering Dialysis Product H-Guard® Completes First In-Human Clinical Study

Study demonstrated safety and tolerability of H-Guard®, a second generation complement regulator, designed to address serious immune system-driven complications of dialysis.Encouraging biomarker data positions H-Guard for upcoming Acute Kidney Injury (AKI) trial focused on reducing complement mediated renal tubu. ....

United Kingdom , Sandip Mitra , Duha Ilyas , Ilyas Duha , Magnus Nicolson , Leonard Ebah , Professor Of Renal Medicine At Manchester University , Care Research , Manchester Clinical Research Facility , National Institute For Health , Invizius Limited , Manchester University , Acute Kidney Injury , Continuous Renal Replacement Therapy , National Institute , Priming Solution , Manchester Royal Infirmary , Professor Sandip Mitra , Intensive Care Unit , Chronic Kidney Disease , Chief Executive Officer , Professor Mitra , Consultant Nephrologist , Renal Medicine , Stockholm May ,

Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm

Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Richard Philipson , Jonathan Barratt , Shikha Wadhwani , Richard Lafayette , Northwestern University , European Renal Association , Renal Medicine At Leicester University , Chief Medical Officer , Poster Presentation , Focused Oral Room , Clinical Markers , Iga Nephropathy , Renal Medicine , Full Prescribing , Primary Immunoglobulin ,